106004-11-9

Basic information

• Product Name: diMethyl bicyclooctane-1,5-dicarboxylate, diMethyl bicyclo[3.2.1]octane-1,5-dicarboxylate
• Synonyms: diMethyl bicyclooctane-1,5-dicarboxylate, diMethyl bicyclo[3.2.1]octane-1,5-dicarboxylate;DiMethyl bicyclo[3.2.1]octane-1,5-dicarboxylate
• CAS NO: 106004-11-9
• Molecular Formula: C₁₂H₁₈O₄
• Molecular Weight: 226.26892
• EINECS: -0
• Mol File: 106004-11-9.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: diMethyl bicyclooctane-1,5-dicarboxylate, diMethyl bicyclo[3.2.1]octane-1,5-dicarboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: diMethyl bicyclooctane-1,5-dicarboxylate, diMethyl bicyclo[3.2.1]octane-1,5-dicarboxylate(106004-11-9)
• EPA Substance Registry System: diMethyl bicyclooctane-1,5-dicarboxylate, diMethyl bicyclo[3.2.1]octane-1,5-dicarboxylate(106004-11-9)

Safety Data

• Hazardous Substances Data: 106004-11-9(Hazardous Substances Data)

Upstream product

• 62638-06-6 dimethyl cyclohexane-1,3-dicarboxylate 
• 107-04-0 1-Bromo-2-chloroethane 
• 106004-10-8 dimethyl 1-(2'-chloroethyl)cyclohexane-1,3-dicarboxylate 
• 3971-31-1 cyclohexane-1,3-dicarboxylic acid 
• 1459-93-4 dimethyl Isophthalate 

Downstream Products

• 110371-27-2 bicyclo[3.2.1]octane-1,5-dicarboxylic acid monomethyl ester 
• 1383973-53-2 benzyl 5-aminobicyclo[3.2.1]octan-1-ylcarbamate 
• 1383973-50-9 N-(5-aminobicyclo[3.2.1]octan-1-yl)-3-fluorobenzamide 
• 1383973-78-1 methyl 5-aminobicyclo[3.2.1]octane-1-carboxylate 
• 1396379-54-6 benzyl 5-carbamoylbicyclo[3.2.1]octan-1-ylcarbamate 
• 1383973-81-6 benzyl 5-(2-methylpyrimidin-4-ylcarbamoyl)bicyclo[3.2.1]octan-1-ylcarbamate 
• 1383971-61-6 N,N'-(bicyclo[3.2.1]octane-1,5-diyl)bis(6-methylpicolinamide) 
• 1383971-60-5 N-(5-(3-chlorobenzamido)bicyclo[3.2.1]octan-1-yl)-6-methylpicolinamide 

Relevant articles and documents

BICYCLO[3.2.1]OCTYL AMIDE DERIVATIVES AND USES OF SAME

The present invention provides bicyclo[3.2.1]octyl amide derivatives of formula (I): wherein L, R1 and R2 are as defined herein, or a pharmaceutically acceptable salt thereof; pharmaceutical compositions and methods using the same.